Pancreatic Cancer /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Neoptolemos, John P. (Editor ), Urrutia, Raul A. (Editor ), Abbruzzese, James. (Editor ), Büchler, Markus W. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2010.
Edición:1st ed. 2010.
Materias:
Tabla de Contenidos:
  • Epidemiology: world overview, risk factors, prospects for prevention
  • Development and structure of pancreas
  • Pathologic classification and biological behaviour of pancreatic neoplasia
  • Developmental molecular biology of the pancreas
  • Molecular pathology of precursor lesions of pancreatic cancer, pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and mucinous cystic neoplasm (MCN)
  • Epigenetics: its fundamentals and applications to a revised comprehensive progression model for pancreatic cancer
  • Molecular pathology of pancreatic neuroendocrine tumours MEN-1: gastrinomas, insulinoma, Non-Functioning Tumours, VIPoma, glucagonoma, Von Hippel-Lindau, Neurofibromatosis
  • Sporadic neuroendocrine pancreatic tumours
  • Molecular pathology of non-pancreatic cancer lesions: Ampullary cancer, intra-pancreatic bile duct cancer, and duodenal cancer
  • Miscellaneous non-pancreatic non-endocrine tumours
  • Novel molecular relationships between chronic pancreatitis and cancer
  • Pancreatic cancer stem cells
  • Cell cycle control: signalling pathways in pancreatic pathogenesis
  • Apoptosis: signalling pathways in pancreatic pathogenesis
  • EGFR: signalling pathways in pancreatic pathogenesis Pl3, Akt, lKK, Ras, Raf, MAPKK, ERK
  • Hedgehog: signalling pathways in pancreatic pathogenesis
  • Smad4/TGF-ß pathway: signalling pathways in pancreatic pathogenesis
  • Notch signalling in pancreatic morphogenesis and pancreatic cancer
  • Molecular characterization of pancreatic cell lines
  • Mouse models of exocrine pancreatic cancer
  • Principles and applications of microarray gene expression in pancreatic cancer
  • Principles and applications of proteomics in pancreatic cancer
  • Tumour-stromal interaction: invasion and metastases
  • Genetic susceptibility, high risk groups, chronic and hereditary pancreatitis, familial pancreatic cancer syndromes
  • Inherited endocrine pancreatic tumors associated with Multiple Endocrine Neoplasia Type 1 Von-Hippel-Lindau Syndrome, and Neurofibromatosis Type 1
  • Clinical decision making in pancreatic cancer
  • Paraneoplastic syndromes
  • Diagnostic and therapeutic response markers
  • CT and fusion PET-CT Diagnosis, staging, and follow-up
  • MRI and MRCP: diagnosis and staging of pancreatic cancer
  • EUS Diagnosis and staging
  • Laparoscopy and laparoscopic ultrasound: diagnosis and staging
  • Overview of palliative management for pancreatic cancer
  • Endoscopy
  • Interventional radiology
  • Role of palliative surgery in advanced pancreatic cancer
  • Chemotherapy for advanced pancreatic cancer
  • Developments in chemoradiation in advanced pancreatic cancer
  • Surgical resection for pancreatic cancer
  • Role of venous resection in pancreatic cancer surgery
  • Pathological reporting and staging following resection
  • Japanese Pancreas Society staging for pancreatic cancer
  • Adjuvant chemotherapy in pancreatic cancer
  • Case for adjuvant chemoradiation therapy for pancreatic cancer
  • Case for neoadjuvant treatment in pancreatic cancer
  • Borderline resectable disease
  • Management of cystic neoplasms serous cystic neoplasms mucinous, cystic neoplasms, intraductal paillary mucinous neoplasms
  • Laparoscopic surgery for pancreatic neoplasm
  • Modern Japanese approach to pancreas cancer
  • Development of novel biomarkers
  • Inherited genetics of pancreatic cancer and secondary screening
  • Gene therapy for pancreatic cancer
  • Vaccine therapy and immunotherapy
  • Emerging targets in pancreatic cancer.-.